Presentation Information

[F2-54]Structure-guided design of receptor-binding domain-down SARS-CoV-2 spike protein to enhance cross-reactivity against variants

*Takuya Hemmi1,2, Saya Moriyama3, Akira Ainai2, Hisano Yajima1, Rin Shirota1, Tomo Nomai4, Shunsuke Kita4, Satoru Nagatoishi5, Kouhei Tsumoto5, Yukihiko Sugita6, Takeshi Noda6, Katsumi Maenaka4, Yoshimasa Takahashi3, Tadaki Suzuki2,7, Takao Hashiguchi1,8 (1. Laboratory of Medical virology, Institute for Life and Medical Sciences, Kyoto University (Japan), 2. Department of Infectious Disease Pathology, National Institute of Infectious Diseases, Japan Institute for Health Security (Japan), 3. Research Center for Vaccine Development, National Institute of Infectious Diseases, Japan Institute for Health Security (Japan), 4. Laboratory of Biomolecular Science and Center for Research and Education on Drug Discovery, Faculty of Pharmaceutical Sciences, Hokkaido University (Japan), 5. Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, Tokyo (Japan), 6. Laboratory of Ultrastructural Virology, Institute for Life and Medical Sciences, Kyoto University, Kyoto (Japan), 7. Department of Infectious Disease Pathobiology, Graduate School of Medicine, Chiba University (Japan), 8. Kyoto University Immunomonitoring Center, Kyoto University (Japan))

Password required to view


Comment

To browse or post comments, you must log in.Log in